What is Alzheimer's disease, and how does it develop?
Alzheimer's disease is the most common form of dementia, accounting for 60 to 70 percent of cases, according to the WHO. It is characterized by a progressive and irreversible degeneration of brain neurons, linked to the accumulation of two abnormal proteins: amyloid plaques (deposits of beta-amyloid peptide between neurons) and neurofibrillary tangles (hyperphosphorylated tau protein inside neurons). These lesions lead to progressive synaptic loss and brain atrophy, initially affecting the hippocampus (episodic memory) and then the entire cerebral cortex. The disease is diagnosed and managed by a medical specialist (neurologist, geriatrician, or psychiatrist)—no over-the-counter product treats or prevents Alzheimer’s disease.
What are the risk factors and early signs?
The most well-established risk factors are:
- Age (the primary risk factor): the prevalence doubles every 5 years after age 65.
- Vascular factors: high blood pressure, type 2 diabetes, high cholesterol, smoking, and a sedentary lifestyle increase the risk of dementia.
- Genetics: The APOE ε4 variant increases the risk by a factor of 3 to 4; familial forms account for less than 5% of cases.
- Potentially modifiable factors (2020 Lancet Commission report): uncorrected hearing loss, depression, social isolation, air pollution, and repeated head trauma.
The first suggestive signs include recent episodic memory impairment, difficulty finding words, disorientation in familiar places, and personality changes. These signs warrant a medical consultation for a neuropsychological evaluation.
Which nutrients are being studied in the context of Alzheimer’s disease?
Several micronutrients are being studied for their potential role in cognitive health and neuroprotection:
- Omega-3 DHA: As essential components of neuronal membranes, they contribute to neuroplasticity and the resolution of brain inflammation. Epidemiological studies link a high intake of DHA to a reduced risk of cognitive decline, although therapeutic clinical trials have not demonstrated a benefit in patients who are already affected.
- Vitamin B12 and folate (vitamin B9): Deficiencies are associated with hyperhomocysteinemia, a documented vascular and neurotoxic risk factor. Correcting vitamin B deficiencies reduces homocysteine levels, which is beneficial for cerebral vascular health.
- Vitamin D3: Severe deficiencies are associated with an increased risk of cognitive decline in epidemiological studies. Supplementation to correct a documented deficiency is recommended in older adults for bone and muscle health.
Do turmeric and resveratrol have neuroprotective benefits?
Several natural polyphenols are currently the subject of active research in the field of neuroprotection:
- Turmeric (curcuminoids): Curcumin has documented anti-amyloid properties in vitro and anti-inflammatory effects. Epidemiological studies have observed a lower prevalence of Alzheimer’s disease in populations with high turmeric consumption, but controlled clinical trials have not demonstrated a significant therapeutic benefit to date.
- Resveratrol: a polyphenol found in red grapes, it activates sirtuins and possesses anti-amyloid properties in vitro. Preliminary clinical trials have shown effects on certain biomarkers, though no conclusive clinical evidence has been established at this stage.
These natural compounds are not treatments for Alzheimer’s disease and should not be used as a substitute for specialized medical care.
What role does sleep play in preventing cognitive decline?
Sleep is a key mechanism for cleansing the brain. During deep sleep, the glymphatic system removes metabolic waste products that have accumulated during wakefulness, including the beta-amyloid peptide. Longitudinal studies show that insufficient sleep duration (<6 hours) or untreated sleep apnea are associated with increased beta-amyloid accumulation and a higher risk of dementia. Aiming for 7 to 9 hours of quality sleep, treating sleep disorders, and maintaining a regular sleep schedule are cognitive hygiene measures that should be incorporated starting in one’s 50s.
How can you support someone with Alzheimer’s on a daily basis?
Support for people with Alzheimer’s disease is based on a comprehensive approach coordinated by a multidisciplinary team:
- Maintaining familiar cues: a stable environment, daily routines, and visual cues to reduce anxiety related to disorientation.
- Cognitive stimulation: memory workshops, crafts, reading, music—evidence suggests that regular cognitive stimulation can slow functional decline.
- Adapted physical activity: 150 minutes of aerobic activity per week reduce the risk of cognitive decline and improve quality of life in the early stages.
- Support for caregivers: The burden on caregivers is considerable. Resources such as France Alzheimer, specialized long-term care facilities (EHPADs), and respite care options (day care, temporary housing) are essential.
